Clinical News
Informatics
Industry News
Medical, Legal, And Practice
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Molecular Imaging: Page 37
German team unveils progress in pancreatic cancer staging
By
Wayne Forrest
Investigators from Heidelberg University Hospital and the German Cancer Research Center are convinced that PET/CT using a fibroblast activation protein molecule inhibitor can open up new applications in staging and restaging of pancreatic ductal adenocarcinoma.
November 3, 2020
IAEA and French group to collaborate on nuclear medicine
By
AuntMinnieEurope.com staff writers
The International Atomic Energy Agency (IAEA) and the French Society of Nuclear Medicine have agreed on a framework for enhanced cooperation in the area of nuclear medicine. The arrangement covers a period of three years from 2020 to 2023.
November 1, 2020
Dutch use molecular scan to find new salivary glands
By
Melissa Busch
A group from the Netherlands Cancer Institute in Amsterdam has used PET/CT with a radiopharmaceutical based on a prostate-specific membrane antigen to discover a pair of salivary glands. Sparing these glands during radiation therapy may prevent treatment side effects and improve quality of life for head and neck cancer patients.
October 29, 2020
AuntMinnieEurope.com Molecular Insider
By
Philip Ward
October 26, 2020
PET/CT rules supreme in cases of neuroendocrine tumors
By
Philip Ward
PET/CT has no rivals when it comes to the detection and surveillance of cardiac metastases in well-differentiated gastroenteropancreatic neuroendocrine tumors as well as guiding clinical management, according to research presented at the annual congress of the European Association of Nuclear Medicine.
October 26, 2020
Dynamic PET edges closer to clinical prime time
By
Frances Rylands-Monk
Dynamic whole-body PET is evolving fast and showing considerable clinical promise, a leading French molecular imaging expert told the opening plenary session at the annual congress of the European Association of Nuclear Medicine. The technique is benefiting from artificial intelligence-based assistance to simplify the challenging and time-consuming tasks associated with the acquisition and analysis of data.
October 26, 2020
Siemens launches PET/CT with large FOV at EANM 2020
By
AuntMinnieEurope.com staff writers
Siemens Healthineers is launching Biograph Vision Quadra, a new PET/CT scanner with a 106-cm axial PET field of view (FOV), at this week's virtual European Association of Nuclear Medicine (EANM) meeting.
October 22, 2020
PET moves ahead in detection of hypoxic tumors
By
Marric Stephens
Researchers have used PET to provide a new way to diagnose hypoxia in tumors. They demonstrated that signs of tumor hypoxia can be spotted among the gamma rays collected routinely during a PET scan, providing clinicians with extra information to guide treatment decisions.
October 20, 2020
U.K., U.S. organizations seek cancer research applicants
By
AuntMinnieEurope.com staff writers
Cancer Research UK and the U.S. National Cancer Institute are seeking research applications to ensure nine core objectives are met.
October 14, 2020
German group refines PET technique for prostate cancer
By
Brian Casey
Researchers from Essen have used a PET-based optical imaging method known as Cerenkov luminescence imaging to highlight the presence of cancer cells after prostate cancer surgery. They published their results in the October edition of the
Journal of Nuclear Medicine
.
October 12, 2020
Compton imaging opens up new diagnostic avenues
By
Tami Freeman, PhD
Compton imaging -- originally developed by astronomers for detecting gamma ray sources -- is now under investigation for clinical imaging. A high-performance Compton camera could prove invaluable for applications within nuclear medicine and molecular imaging, researchers have found.
October 8, 2020
Moscow PET facilities make change to prostate scans
By
AuntMinnieEurope.com staff writers
Providers of PET services in Moscow have started using a radiopharmaceutical agent, F-18 prostate-specific membrane antigen, for a more accurate diagnosis of prostate cancer, according to a statement issued by the Research and Practical Clinical Center of Diagnostics and Telemedicine Technologies in Russia.
October 4, 2020
Previous Page
Page 37 of 121
Next Page